Trident Lifeline

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MKA01014
  • NSEID:
  • BSEID: 543616
INR
406.05
-3.95 (-0.96%)
BSENSE

Nov 20

BSE+NSE Vol: 10800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Valiant Laborato
Albert David
Trident Lifeline
Medicamen Biotec
Jenburkt Pharma
Haleos Labs Limi
Wanbury
Transchem
Astonea Labs
Ennature Bio Pha
Infinium Pharma
Why is Trident Lifeline Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.17 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 56.00% and Operating profit at 72.14%
3
Positive results in Sep 26
  • PBT LESS OI(Q) At Rs 7.84 cr has Grown at 46.7% (vs previous 4Q average)
  • NET SALES(Q) At Rs 47.08 cr has Grown at 33.8% (vs previous 4Q average)
  • PBDIT(Q) Highest at Rs 11.32 cr.
4
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 17-Sep-26 and has generated 32.89% returns since then
  • The stocks MACD and KST technical factors are also Bullish
5
With ROCE of 14.5, it has a Expensive valuation with a 2.9 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 30.17%, its profits have risen by 62%
6
Market Beating performance in long term as well as near term
  • Along with generating 30.17% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Trident Lifeline should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Trident Lifeline for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Trident Lifeline
30.17%
0.59
51.38%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
56.00%
EBIT Growth (5y)
72.14%
EBIT to Interest (avg)
5.65
Debt to EBITDA (avg)
3.36
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.68
Tax Ratio
27.86%
Dividend Payout Ratio
0
Pledged Shares
11.25%
Institutional Holding
1.37%
ROCE (avg)
9.74%
ROE (avg)
18.49%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
21
Industry P/E
40
Price to Book Value
4.27
EV to EBIT
19.71
EV to EBITDA
15.94
EV to Capital Employed
2.87
EV to Sales
3.66
PEG Ratio
NA
Dividend Yield
0.12%
ROCE (Latest)
14.55%
ROE (Latest)
19.91%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
PBT LESS OI(Q)

At Rs 7.84 cr has Grown at 46.7% (vs previous 4Q average

NET SALES(Q)

At Rs 47.08 cr has Grown at 33.8% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 11.32 cr.

PAT(Q)

At Rs 6.60 cr has Grown at 25.7% (vs previous 4Q average

EPS(Q)

Highest at Rs 5.69

-11What is not working for the Company
ROCE(HY)

Lowest at 20.82%

DEBT-EQUITY RATIO(HY)

Highest at 0.38 times

INTEREST(Q)

Highest at Rs 1.93 cr

Loading Valuation Snapshot...
Here's what is working for Trident Lifeline
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 7.84 cr has Grown at 46.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 5.35 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
At Rs 47.08 cr has Grown at 33.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 35.18 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 11.32 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 6.60 cr has Grown at 25.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 5.25 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 5.69
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Trident Lifeline
Interest - Quarterly
At Rs 1.93 cr has Grown at 192,999,900.00%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 1.93 cr
in the last five quarters and Increased by 192,999,900.00 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debt-Equity Ratio - Half Yearly
Highest at 0.38 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio